GBM Ventures

GBM Ventures is the corporate venture arm of Grupo Bursatil Mexicano, one of Mexico’s most established financial services groups, and operates with $250k-$1M cheques at Seed and Series A. The firm’s strategic emphasis is fintech and adjacent infrastructure software, with selective exposure to health IT and digital health platforms that intersect with payment, insurance, or financial services rails. For founders, GBM Ventures is best positioned as a strategic CVC for digital health platforms with a credible distribution or payment angle that connects to GBM’s wealth management or brokerage customer base. The right founder profile is a Mexican or LatAm operator building B2B health IT software, insurance-tech health, or platforms that monetise through embedded finance. Pure clinical software, biotech, and consumer wellness founders without a finance hook should not approach. Entry path is through GBM’s strategy team, an existing portfolio CEO, or warm introductions from Mexico City-based VCs that co-invest (Angel Ventures, ALLVP, 500 LATAM). In the pitch, lead with payment economics, integration roadmap with GBM’s services where relevant, and traction with Mexican enterprise or SMB customers. Caveats: as a CVC inside a regulated financial group, GBM Ventures has institutional decision processes and term sheets may include strategic terms (right of first refusal, data sharing) that founders should negotiate. The fund is not an AI-thesis specialist, so AI claims will be evaluated commercially rather than technically. Founders should request a recent deal sheet to confirm health-specific exposure, since the firm’s healthcare cadence is uneven and most deal flow tracks the fintech mandate. Reserves and follow-on policy should be clarified explicitly during initial diligence.